Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002895 (
sickle cell disease
)
11,747
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We compiled the results of pars plana vitrectomy in rare proliferative and hemorrhagic diseases. In retinal vasculitis of unknown origin (perhaps Eales' disease), six out of seven eyes had visual improvement; in
sickle cell disease
, two out of three eyes improved. Three eyes with presumed toxocariasis were successfully treated. In
retrolental fibroplasia
(
RLF
), only lighter degrees of the cicatricial stage with traction detachments can be treated. Some cases may simulate Coats' disease. There are also cases which simulate the typical picture of
RLF
, where there is no history of prematurity or oxygen usage. Five patients with
RLF
were treated, three of these successfully. Cryoglobulinemia (one case) and hereditary hemorrhagic telangiectasia (one case) were successfully treated. Senile macular degeneration can also be an indication for vitrectomy (two out of three eyes were successfully treated).
...
PMID:Results of vitrectomy for rare proliferative and hemorrhagic diseases. 57 91
ROP
is a challenging disease of the decade of the 1980s. Answers, even partial answers, to many of its questions may provide information bearing on those same questions in other blinding vascular retinopathies, such as diabetes and
sickle cell disease
. Answers more clearly defining the role of oxygen, ventilation, antioxidants, blood transfusions, and a host of diseases of the premature infant will lead to better care of that infant. I have tried in this article to present the boundaries of the problem, a theory of its genesis and progression, and a review of the major issues to be confronted by the pediatric, ophthalmologic, and basic science communities through its recurrence today. I have tried to make it clear to the reader when I was so doing. I have used information liberally from studies both under way and in the planning stages to make the reader aware of what is being done, even if these have not yet reached fruition, for the field is a rapidly growing one. Finally, I have tried to point out directions that I believe clinical and experimental work should take on certain critical issues.
...
PMID:Retinopathy of prematurity. 331 43
Retinal neovascularization is a serious complication of the retinopathy associated with diabetes, branch vein occlusion,
sickle cell anemia
, and
retrolental fibroplasia
. Retinal capillary nonperfusion, demonstrated on fluorescein angiography, precedes the development of neovascularization in each of these conditions. Our working hypothesis is that the nonperfused (ischemic or hypoxic) retina liberates a vasoproliferative or angiogenic substance. Although I have delineated the clinical and experimental observations relating to the hypothesis of an ischemic-mediated angiogenesis substance, other postulated mechanisms for the development of retinal neovascularization may be involved. Recent observations on the experimental model of
retrolental fibroplasia
have demonstrated the markedly abnormal persistence and apparent proliferation of the hyaloid vessels in mice following oxygen-induced retinal vascular closure.
...
PMID:Clinical and experimental studies on retinal neovascularization. XXXIX Edward Jackson Memorial Lecture. 618 97
Neovascularization leads to blindness in numerous ocular diseases, including diabetic retinopathy, age-related macular degeneration,
retinopathy of prematurity
, and
sickle cell disease
. More effective and stable treatments for ocular neovascularization are needed, yet there are major limitations in the present animal models. To develop primate models of diabetic retinopathy and choroidal neovascularization, rhesus monkeys were injected subretinally or intravitreally with an adeno-associated virus (AAV)-2 vector carrying the cDNA encoding human vascular endothelial growth factor (VEGF). Overexpression of VEGF was measured by intraocular fluid sampling over time. Neovascularization was evaluated by ophthalmoscopy through angiography, optical coherence tomography, and ultimately histopathology. Overexpression of VEGF through AAV2 results in rapid development of features of diabetic retinopathy or macular edema, depending on the targeted cell type/mode of production of VEGF and diffusion of VEGF. Nonhuman primate models will be useful in testing long-term safety and efficacy of novel therapeutic agents for blinding neovascular diseases.
...
PMID:Nonhuman primate models for diabetic ocular neovascularization using AAV2-mediated overexpression of vascular endothelial growth factor. 1579 54
Retinal vasoproliferative tumor is a rare disease that has capillary hemangioma as the most frequent diferential diagnosis. The tumor is considered to be of reactive nature. It can be idiophatic or secondary to other ocular diseases such as: uveitis, retinitis pigmentosa,
sickle cell disease
, previous surgery and
retinopathy of prematurity
. Lesions with no exsudation or visual decrease can be observed. Lesions that need treatment can be managed by on or more modalities such as cryotherapy, a variety of lasers, surgical excision, radiation, and antiangiogenic intravitreal injections.
...
PMID:Retinal vasoproliferative tumor. 2392 86